EMA — authorised 4 February 2009
- Status: approved
EMA authorised Nplate on 4 February 2009
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 4 February 2009.
Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.